Richard Gehrig
About Richard Gehrig
Richard Gehrig is the Director of Scientific Engagement, Oncology Marketing – US at Bristol-Myers Squibb and also serves as the Director of Global Marketing, Solid Tumors at Genmab in Plainsboro, New Jersey.
Company
Richard Gehrig currently holds the position of Director, Global Marketing, Solid Tumors at Genmab in Plainsboro, New Jersey, United States. Additionally, he serves as Director, Scientific Engagement, Oncology Marketing – US at Bristol-Myers Squibb.
Title
Richard Gehrig is the Director of Scientific Engagement, Oncology Marketing – US at Bristol-Myers Squibb and also serves as the Director of Global Marketing for Solid Tumors at Genmab.
Background
Richard Gehrig has amassed over 20 years of experience in the pharmaceutical industry, primarily focusing on oncology marketing. He initially started his career at Bristol-Myers Squibb as a Sr. Administrative Associate and has transitioned through various significant roles over the years. His career trajectory includes positions such as Territory Business Manager, Manager of Oncology Sales Training, Product Manager for ERBITUX marketing, Associate Director for Opdivo US Marketing in both Head and Neck Cancer and Non-Small Cell Lung Cancer, and District Business Manager.
Education and Expertise
Richard Gehrig holds educational credentials from Drew University, where he studied for a year, and Stockton University, where he completed a four-year program. His career demonstrates substantial expertise in oncology marketing, particularly in scientific engagement and managing marketing strategies for products used in cancer treatment like ERBITUX and Opdivo.
Achievements
Throughout his extensive career at Bristol-Myers Squibb, Richard Gehrig has held multiple significant roles that contribute to his expertise in oncology marketing. Notable positions include heading the marketing efforts for Opdivo in both head and neck cancer and non-small cell lung cancer. His strategic role in marketing ERBITUX, a cancer treatment drug, for three years also stands out. His experience in various leadership roles highlights his capability in managing scientific engagement and oncology marketing in the U.S.